haloperidol has been researched along with Delusional Disorder in 130 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sertindole is a new antipsychotic agent effective for the treatment of both the positive and negative symptoms of schizophrenia, with motor side effects that are indistinguishable from those associated with placebo." | 9.08 | Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. ( Daniel, DG; Kane, JM; Kashkin, KB; Mack, RJ; Sebree, TB; Tamminga, CA; Wallin, BA; Wozniak, PJ; Zimbroff, DL, 1997) |
| "In two double-blind trials conducted in North America, 513 patients with chronic schizophrenia received risperidone, haloperidol, or placebo." | 9.08 | The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. ( Chouinard, G; Davis, JM; Marder, SR, 1997) |
| "To report a case of delayed-onset dystonic reactions, oculogyric crisis (OGC), and torticollis after treatment with intramuscular haloperidol lactate injection." | 7.72 | Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol. ( Jhee, SS; Mohaupt, SM; Sims, SJ; Yones, CL; Zarotsky, V, 2003) |
| "Several cases of torsade de pointes have been reported in association with the use of oral haloperidol." | 6.40 | Torsade de pointes and low-dose oral haloperidol. ( Ditmanson, L; Jackson, T; Phibbs, B, 1997) |
| "Two typical recurrent episodes of neuroleptic malignant syndrome (NMS) in the same patient are described." | 5.27 | Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors. ( Hermesh, H; Huberman, M; Kott, E; Radvan, H, 1984) |
| " The objective of this study was to examine the antipsychotic effect and side effect profile of amoxapine versus haloperidol in a double-blind study for 6 weeks in patients with schizophrenia." | 5.12 | Amoxapine as an antipsychotic: comparative study versus haloperidol. ( Badshah, S; Chaudhry, IB; Deakin, B; Husain, N; Kapur, S; Khan, S, 2007) |
| "Sertindole is a new antipsychotic agent effective for the treatment of both the positive and negative symptoms of schizophrenia, with motor side effects that are indistinguishable from those associated with placebo." | 5.08 | Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. ( Daniel, DG; Kane, JM; Kashkin, KB; Mack, RJ; Sebree, TB; Tamminga, CA; Wallin, BA; Wozniak, PJ; Zimbroff, DL, 1997) |
| "In two double-blind trials conducted in North America, 513 patients with chronic schizophrenia received risperidone, haloperidol, or placebo." | 5.08 | The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. ( Chouinard, G; Davis, JM; Marder, SR, 1997) |
| "To report a case of delayed-onset dystonic reactions, oculogyric crisis (OGC), and torticollis after treatment with intramuscular haloperidol lactate injection." | 3.72 | Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol. ( Jhee, SS; Mohaupt, SM; Sims, SJ; Yones, CL; Zarotsky, V, 2003) |
| "The enhancement of immobility in a forced swimming test of mice induced by repeated treatment with phencyclidine and amphetamine swimming "normalization" test of mice were used as animal models of negative and positive symptoms of schizophrenia, respectively." | 3.70 | Atypical antipsychotic effects of quetiapine fumarate in animal models. ( Dai, J; Guan, HJ; Zhu, XZ, 2000) |
| " Adjunctive treatment with clonazepam resulted in the cessation of the seizures and of persistent, violent hallucinations." | 3.67 | Antiaggressive effect of adjunctive clonazepam in schizophrenia associated with seizure disorder. ( Keats, MM; Mukherjee, S, 1988) |
| " In the individually treated group the dosage was determined by a senior psychiatrist at the hospital who was not involved in collecting the data of the investigation; neither the nursing staff nor the physicians involved in thus study were informed of the dosages." | 2.67 | [Disagreement in standardized haloperidol treatment in comparison with "adequate individual dosage" of acutely schizophrenic patients]. ( Klieser, E; Lehmann, E, 1992) |
| "Fluperlapine (NB-106-689) was tested on 26 schizophrenic patients in an open and crossover study." | 2.66 | Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study. ( Bartels, M; Gärtner, HJ; Heimann, H; Mann, K; Schied, HW; Wagner, W, 1987) |
| "The drug difference between a low and a high dosage of haloperidol was investigated in 40 acutely ill schizophrenic patients." | 2.65 | Effects of high and low dosage of haloperidol on the brain in relation to schizophrenic thought disorder. ( Lehmann, E; Scholz, OB; Winter, M, 1984) |
| "Several cases of torsade de pointes have been reported in association with the use of oral haloperidol." | 2.40 | Torsade de pointes and low-dose oral haloperidol. ( Ditmanson, L; Jackson, T; Phibbs, B, 1997) |
| "Neuroleptic malignant syndrome is difficult to distinguish from febrile catatonia and the diagnosis can often only be made through the clinical course." | 2.39 | [The neuroleptic malignant syndrome]. ( Agelink, MW; Dammers, S; Leonhardt, M; Schär, V; Zeit, T, 1995) |
| "Schizophrenia is thought to be the psychiatric diagnosis the most frequently associated with TD." | 1.39 | [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics]. ( Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I, 2013) |
| "Transient, postictal cortical blindness is a rare adverse effect of electroconvulsive therapy (ECT)." | 1.38 | Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness. ( Andrade, C; Bambole, V; Bang, A; Shah, N; Sonavane, S, 2012) |
| "The dominant patient was diagnosed with schizoaffective disorder and her non-dominant sister with paranoid schizophrenia." | 1.37 | Folie à deux: double case-report of shared delusions with a fatal outcome. ( Di Cosimo, D; Girardi, N; Kotzalidis, GD; Lazanio, S; Manfredi, G; Savoja, V; Talamo, A; Tatarelli, R; Vento, A, 2011) |
| "Pimozide has been mooted as specific for the treatment of this condition." | 1.36 | Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients. ( Kenchaiah, BK; Kumar, S; Tharyan, P, 2010) |
| "Treatment with risperidone solution orally or parenteral haloperidol until the day after admission, followed by olanzapine, successfully improved the clinical condition of the patients." | 1.35 | Three cases of schizophrenia for which olanzapine was effective after early acute phase. ( Inada, T; Oda, T; Yamamoto, N, 2008) |
| "Upon treatment with diazepam and haloperidol, the psychosis subsided within three days." | 1.34 | [Postictal paranoid-hallucinatory psychosis in cryptogenic epilepsy]. ( Baum, P; Hermann, W; Kopf, A; Wagner, A, 2007) |
| "A 45-year-old man with paranoid schizophrenia repeatedly developed hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH), both after treatment with haloperidol and after taking quetiapine." | 1.33 | [The syndrome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine]. ( Bet, PM; Eeckhout, AM; van Dam, EW; van den Heuvel, OA, 2006) |
| " The main effect of the long-term administration of haloperidol seems to be an increase of cerebellar, basal ganglia and motor area metabolism." | 1.32 | Cerebral metabolic patterns in chronic and recent-onset schizophrenia. ( Benito, C; Desco, M; Gispert, JD; Molina, V; Palomo, T; Pascau, J; Reig, S; Santos, A; Sanz, J; Sarramea, F, 2003) |
| " A mean therapeutic dosage for Seroquel was 316." | 1.32 | [Influence of long-term quetiapine (Seroquel) and haloperidol therapy on cognitive deficit in patients with paranoid schizophrenia]. ( Kabanov, SO; Mosolov, SN, 2004) |
| " We tested this hypothesis by investigating stereotyped behavior and "reverse tolerance" in dopaminergic supersensitivity co-existing with a low-level activity of the inhibitory cholinergic system induced by the chronic administration of methamphetamine (MAP) 4 mg/kg in combination with scopolamine (SCOP) 0." | 1.28 | [Cholinergic modulation on stereotyped behavior and behavioral hypersensitivity (reverse tolerance) in rats]. ( Miura, T; Yui, K, 1991) |
| "Two typical recurrent episodes of neuroleptic malignant syndrome (NMS) in the same patient are described." | 1.27 | Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors. ( Hermesh, H; Huberman, M; Kott, E; Radvan, H, 1984) |
| " An experimental study of the long-term administrations of haloperidol revealed the formation of adaptation to the drug which can be overcome by a zigzag-like sharp elevation of the dosage followed by rapid reduction to the baseline level." | 1.27 | [Various methods of overcoming secondary resistance to treatment developing in relation to adaptation to psychotropic drugs during long-term treatment (clinico-experimental study)]. ( Allikmets, LKh; Avrutskiĭ, GIa; Beliakov, AV; Neduva, AA; Zharkovskiĭ, AM, 1984) |
| "Patients with paranoid schizophrenia display fully or partially unstable circadian rhythms." | 1.27 | [Treatment of paranoid schizophrenia taking circadian biological rhythms into account]. ( Tsaritsinskiĭ, VI, 1984) |
| "We report a patient in whom Tourette's syndrome (TS) and Type I schizophrenia coincided, and suggest, based on clinical features and pharmacological responses, that both conditions in this patient could have a common pathophysiological basis." | 1.27 | Gilles de la Tourette's syndrome associated with chronic schizophrenia. ( Bamford, CR; Sandyk, R, 1988) |
| "Diminution of catalepsy was explained by a decrease of the blocking effect of the neuroleptic on the dopamine system." | 1.27 | [Adaptation to neuroleptic preparations and several ways of combatting it (experimental study)]. ( Beliakov, AV; Matvienko, OA; Neduva, AA; Zharkovskiĭ, AM, 1985) |
| "The authors report a case of unexpected sudden death in a woman receiving relatively high dose of haloperidol." | 1.26 | A fatality during haloperidol treatment: mechanism of sudden death. ( Böker, W; Krapf, R; Modestin, J, 1981) |
| " Plasma prolactin levels, initially high, increased when the dosage was increased to 100 mg/day but did not increase further." | 1.26 | High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study. ( Bianchetti, G; Cuche, H; Loo, H; Morselli, PL; Scatton, B; Zarifian, E, 1982) |
| "Haloperidol was given for 30 days, at a daily dose of 6 mg i." | 1.25 | Growth hormone secretion in chronic schizophrenia. ( Brambilla, F; Guastalla, A; Guerrini, A; Recchia, M; Riggi, F; Rovere, C, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 64 (49.23) | 18.7374 |
| 1990's | 28 (21.54) | 18.2507 |
| 2000's | 28 (21.54) | 29.6817 |
| 2010's | 10 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, YP | 1 |
| Yang, SW | 1 |
| Ajiboye, PO | 1 |
| Yusuf, AD | 1 |
| Oluwole, LO | 1 |
| Dada, MU | 1 |
| Obadeji, A | 1 |
| Sarkhel, S | 1 |
| Singh, N | 1 |
| Praharaj, SK | 1 |
| Williams, JB | 1 |
| Hewer, W | 2 |
| Kauder, E | 1 |
| Vierling, P | 1 |
| Cerimele, JM | 1 |
| Stern, AP | 1 |
| Jutras-Aswad, D | 1 |
| Kenchaiah, BK | 1 |
| Kumar, S | 1 |
| Tharyan, P | 1 |
| Talamo, A | 1 |
| Vento, A | 1 |
| Savoja, V | 1 |
| Di Cosimo, D | 1 |
| Lazanio, S | 1 |
| Kotzalidis, GD | 1 |
| Manfredi, G | 1 |
| Girardi, N | 1 |
| Tatarelli, R | 1 |
| Sonavane, S | 1 |
| Bambole, V | 1 |
| Bang, A | 1 |
| Shah, N | 1 |
| Andrade, C | 1 |
| Sejil, I | 1 |
| Oumaya, A | 1 |
| Bouguerra, C | 1 |
| Mehdi, F | 1 |
| Bellaaj, R | 1 |
| Gallali, S | 1 |
| Atmaca, M | 1 |
| Kuloglu, M | 1 |
| Buyukbayram, A | 1 |
| Tezcan, E | 1 |
| Molina, V | 2 |
| Gispert, JD | 2 |
| Reig, S | 2 |
| Sanz, J | 2 |
| Pascau, J | 2 |
| Santos, A | 2 |
| Palomo, T | 2 |
| Desco, M | 2 |
| Miller, DD | 1 |
| Sarramea, F | 1 |
| Benito, C | 1 |
| Sattar, SP | 1 |
| Fernandes, P | 1 |
| Bhatia, SC | 1 |
| ALEKSANDROVSKII, IuA | 1 |
| Jhee, SS | 1 |
| Zarotsky, V | 1 |
| Mohaupt, SM | 1 |
| Yones, CL | 1 |
| Sims, SJ | 1 |
| Sacchetti, E | 1 |
| Valsecchi, P | 1 |
| Ehrenreich, H | 1 |
| Degner, D | 1 |
| Meller, J | 1 |
| Brines, M | 1 |
| Béhé, M | 1 |
| Hasselblatt, M | 1 |
| Woldt, H | 1 |
| Falkai, P | 1 |
| Knerlich, F | 1 |
| Jacob, S | 1 |
| von Ahsen, N | 1 |
| Maier, W | 1 |
| Brück, W | 1 |
| Rüther, E | 2 |
| Cerami, A | 1 |
| Becker, W | 1 |
| Sirén, AL | 1 |
| Howes, O | 1 |
| Smith, S | 1 |
| Flynn, SW | 1 |
| Mosolov, SN | 1 |
| Kabanov, SO | 1 |
| Nechifor, M | 1 |
| Vaideanu, C | 1 |
| Palamaru, I | 1 |
| Borza, C | 1 |
| Mindreci, I | 1 |
| Wolf, K | 1 |
| Veismann, S | 1 |
| Knecht, G | 1 |
| Naber, D | 1 |
| van den Heuvel, OA | 1 |
| Bet, PM | 1 |
| van Dam, EW | 1 |
| Eeckhout, AM | 1 |
| O'Brien, CP | 1 |
| DiGiacomo, JN | 1 |
| Webb, W | 1 |
| Chaudhry, IB | 1 |
| Husain, N | 1 |
| Khan, S | 1 |
| Badshah, S | 1 |
| Deakin, B | 1 |
| Kapur, S | 3 |
| Baum, P | 1 |
| Kopf, A | 1 |
| Hermann, W | 1 |
| Wagner, A | 1 |
| Yamamoto, N | 1 |
| Oda, T | 1 |
| Inada, T | 1 |
| Shibley, H | 1 |
| Pelic, C | 1 |
| Kahn, DA | 1 |
| Schmidt, LG | 1 |
| Schüssler, G | 1 |
| Kappes, CV | 1 |
| Müller-Oerlinghausen, B | 1 |
| Extein, I | 1 |
| Pottash, AL | 1 |
| Gold, MS | 1 |
| Gattaz, WF | 9 |
| Cramer, H | 2 |
| Beckmann, H | 5 |
| Youssef, HA | 1 |
| Allen, RM | 1 |
| Waldmeier, P | 1 |
| Lauber, J | 1 |
| Hermesh, H | 1 |
| Huberman, M | 1 |
| Radvan, H | 1 |
| Kott, E | 1 |
| Lehmann, E | 3 |
| Lienert, GA | 1 |
| Bourguignon, A | 1 |
| Monfort, JC | 1 |
| de Medeiros, P | 1 |
| Cadet, B | 1 |
| Chaneac, D | 1 |
| Avrutskiĭ, GIa | 2 |
| Allikmets, LKh | 1 |
| Neduva, AA | 2 |
| Zharkovskiĭ, AM | 2 |
| Beliakov, AV | 2 |
| Linkowski, P | 1 |
| Hubain, P | 1 |
| von Frenckell, R | 1 |
| Mendlewicz, J | 1 |
| Winter, M | 1 |
| Scholz, OB | 1 |
| Riederer, P | 1 |
| Reynolds, GP | 1 |
| Gattaz, D | 2 |
| Yasukawa, M | 1 |
| Hatakeyama, Y | 1 |
| Yasukawa, K | 1 |
| Chiba, S | 1 |
| Suzuki, T | 1 |
| Takami, T | 1 |
| Shenoy, RS | 1 |
| Ettigi, P | 1 |
| Johnson, CH | 1 |
| Tsaritsinskiĭ, VI | 1 |
| Mosketi, KV | 1 |
| Mokhovikov, AN | 1 |
| Aksent'ev, SB | 1 |
| Goĭkhberg, IG | 1 |
| Kryzhanovskiĭ, GN | 1 |
| Sato, M | 1 |
| Chen, CC | 1 |
| Akiyama, K | 1 |
| Otsuki, S | 1 |
| Zarifian, E | 1 |
| Scatton, B | 1 |
| Bianchetti, G | 1 |
| Cuche, H | 1 |
| Loo, H | 1 |
| Morselli, PL | 1 |
| Multani, HS | 1 |
| Varma, GK | 1 |
| Modestin, J | 1 |
| Krapf, R | 1 |
| Böker, W | 1 |
| Annitto, WJ | 1 |
| Layman, WA | 1 |
| Silva, JA | 1 |
| Leong, GB | 1 |
| Weinstock, R | 1 |
| Klein, RL | 1 |
| Palao, DJ | 1 |
| Arauxo, A | 1 |
| Brunet, M | 1 |
| Bernardo, M | 1 |
| Haro, JM | 1 |
| Ferrer, J | 1 |
| Gonzalez-Monclus, E | 1 |
| Schellenberg, R | 1 |
| Milch, W | 1 |
| Schwarz, A | 1 |
| Schober, F | 1 |
| Dimpfel, W | 1 |
| Buhrich, N | 1 |
| Hayman, J | 1 |
| Forman, SD | 1 |
| Bissette, G | 1 |
| Yao, J | 1 |
| Nemeroff, CB | 1 |
| van Kammen, DP | 1 |
| Tényi, T | 1 |
| Trixler, M | 1 |
| Leroux, JM | 1 |
| Elia, E | 1 |
| Jacquet, M | 1 |
| Pommery, J | 1 |
| Levron, JC | 1 |
| Bouhours, P | 1 |
| Erb, F | 1 |
| Sechter, D | 1 |
| Lindenmeyer, JP | 1 |
| Dammers, S | 1 |
| Zeit, T | 1 |
| Leonhardt, M | 1 |
| Schär, V | 1 |
| Agelink, MW | 1 |
| Röther, J | 1 |
| Jakob, J | 1 |
| Bender, HJ | 1 |
| Schlegel, S | 2 |
| Schlösser, R | 2 |
| Hiemke, C | 2 |
| Nickel, O | 2 |
| Bockisch, A | 2 |
| Hahn, K | 2 |
| Bharucha, KJ | 1 |
| Sethi, KD | 1 |
| Zimbroff, DL | 1 |
| Kane, JM | 1 |
| Tamminga, CA | 1 |
| Daniel, DG | 1 |
| Mack, RJ | 1 |
| Wozniak, PJ | 1 |
| Sebree, TB | 1 |
| Wallin, BA | 1 |
| Kashkin, KB | 1 |
| Jackson, T | 1 |
| Ditmanson, L | 1 |
| Phibbs, B | 1 |
| Rao, ML | 1 |
| Marder, SR | 1 |
| Davis, JM | 1 |
| Chouinard, G | 1 |
| Spisla, C | 1 |
| Bünter, M | 1 |
| McClure, FS | 1 |
| Gladsjo, JA | 1 |
| Jeste, DV | 1 |
| Fitzgerald, PB | 2 |
| Caligiuri, MP | 1 |
| Jones, C | 1 |
| Silvestri, S | 1 |
| Remington, G | 2 |
| Zipursky, RB | 2 |
| Roy, P | 1 |
| Künstler, U | 1 |
| Hohdorf, K | 1 |
| Regenthal, R | 1 |
| Seese, A | 1 |
| Gertz, HJ | 1 |
| Spencer, J | 1 |
| Weitzel, C | 1 |
| Guan, HJ | 1 |
| Dai, J | 1 |
| Zhu, XZ | 1 |
| Talvik, M | 1 |
| Nordström, AL | 1 |
| Nyberg, S | 1 |
| Olsson, H | 1 |
| Halldin, C | 1 |
| Farde, L | 1 |
| Marilov, VV | 1 |
| Shiloh, R | 1 |
| Weizman, A | 1 |
| Dorfman-Etrog, P | 1 |
| Weizer, N | 1 |
| Munitz, H | 1 |
| Angelopoulos, EK | 1 |
| Markianos, M | 2 |
| Daskalopoulou, EG | 1 |
| Hatzimanolis, J | 2 |
| Tzemos, J | 1 |
| Danilenko, ET | 1 |
| Oleĭnikov, VI | 1 |
| Cavenar, JO | 1 |
| Braasch, ER | 1 |
| Sullivan, JL | 1 |
| Brambilla, F | 3 |
| Guerrini, A | 3 |
| Guastalla, A | 3 |
| Rovere, C | 3 |
| Riggi, F | 3 |
| Cassano, GB | 1 |
| Castrogiovanni, P | 1 |
| Conti, L | 1 |
| Bonollo, L | 1 |
| Kay, SR | 1 |
| Singh, MM | 2 |
| De Fraites, EG | 1 |
| Davis, KL | 1 |
| Berger, PA | 1 |
| Itil, TM | 1 |
| Marasa, J | 1 |
| Saletu, B | 1 |
| Davis, S | 1 |
| Mucciardi, AN | 1 |
| Sheppard, C | 1 |
| Beyel, V | 1 |
| Moan, E | 1 |
| Fracchia, J | 1 |
| Merlis, S | 1 |
| Recchia, M | 1 |
| Mombour, W | 1 |
| Kockott, G | 1 |
| Fliege, K | 1 |
| Zanoboni, A | 1 |
| Zanoboni-Muciaccia, W | 1 |
| Bajulaiye, R | 1 |
| Klieser, E | 1 |
| Govorin, NV | 1 |
| Lozhkina, AN | 1 |
| Fleischhacker, WW | 1 |
| Barnas, C | 1 |
| Stuppäck, CH | 1 |
| Sperner-Unterweger, B | 1 |
| Miller, C | 1 |
| Hinterhuber, H | 1 |
| Rabey, JM | 1 |
| Lerner, A | 1 |
| Sigal, M | 1 |
| Graff, E | 1 |
| Oberman, Z | 1 |
| Paunović, VR | 1 |
| Timotijević, I | 1 |
| Marinković, D | 1 |
| Cournoyer, J | 1 |
| Monette, Y | 1 |
| Yui, K | 1 |
| Miura, T | 1 |
| Remington, GJ | 1 |
| Voineskos, G | 1 |
| Pollock, B | 1 |
| Reed, K | 1 |
| Coulter, K | 1 |
| Rinieris, P | 1 |
| Stefanis, C | 1 |
| Bersani, G | 1 |
| Valeri, M | 1 |
| Bersani, I | 1 |
| Piazza, A | 1 |
| Adorno, D | 1 |
| Casciani, CU | 1 |
| Ciani, N | 1 |
| Rost, W | 1 |
| Hübner, CK | 1 |
| Bauer, K | 1 |
| Fuller, MA | 1 |
| Sajatovic, M | 1 |
| Möller, HJ | 1 |
| von Zerssen, D | 1 |
| Rissler, K | 1 |
| Mann, K | 1 |
| Bartels, M | 1 |
| Gärtner, HJ | 1 |
| Schied, HW | 1 |
| Wagner, W | 1 |
| Heimann, H | 1 |
| Sandyk, R | 1 |
| Bamford, CR | 1 |
| McNally, RJ | 1 |
| Calamari, JE | 1 |
| Keats, MM | 1 |
| Mukherjee, S | 1 |
| Morera, A | 1 |
| Estrada, AG | 1 |
| Valenciano, R | 1 |
| Kushnir, SL | 1 |
| Rampertaap, MP | 1 |
| Köllisch, M | 2 |
| Thuren, T | 1 |
| Virtanen, JA | 1 |
| Kinnunen, PK | 1 |
| Hejazi, M | 1 |
| Heim, M | 1 |
| Roberts, E | 1 |
| Lang, RE | 1 |
| Schlör, KH | 1 |
| Moises, HW | 1 |
| Haas, S | 1 |
| Rieger, H | 1 |
| Gomez, EA | 1 |
| Matvienko, OA | 1 |
| Lawlor, BA | 1 |
| Stewart, JT | 1 |
| Hollister, LE | 1 |
| Gurovich, IIa | 1 |
| Prokhorova, IS | 1 |
| Tirkel'taub, IuA | 1 |
| Romanov, IuD | 1 |
| Man, PL | 1 |
| Eben, E | 1 |
| Ackenheil, M | 1 |
| Raese, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Risperidone Versus Haloperidol Versus Placebo in the Treatment of Chronic Schizophrenia[NCT00249132] | Phase 3 | 523 participants (Actual) | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for haloperidol and Delusional Disorder
| Article | Year |
|---|---|
[The neuroleptic malignant syndrome].
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benperidol; Combined Modality Therapy | 1995 |
Tardive tourettism after exposure to neuroleptic therapy.
Topics: Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male | 1995 |
Torsade de pointes and low-dose oral haloperidol.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; | 1997 |
Antiparkinson drugs in paranoid schizophrenia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Haloperidol; Humans; Perphenazin | 1979 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differ | 1986 |
21 trials available for haloperidol and Delusional Disorder
| Article | Year |
|---|---|
Erythropoietin: a candidate compound for neuroprotection in schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antipsychotic Agents; Cell Death; Cells, Cultured; Cognitio | 2004 |
The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Biomarkers; Calcium; Copper; Erythrocytes; Female; Ha | 2004 |
Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
Topics: Adult; Antipsychotic Agents; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method | 1974 |
Amoxapine as an antipsychotic: comparative study versus haloperidol.
Topics: Adolescent; Adult; Age Factors; Amoxapine; Antidepressive Agents, Second-Generation; Antipsychotic A | 2007 |
[Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics].
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combinat | 1984 |
Differential improvements from haloperidol in two types of schizophrenics.
Topics: Haloperidol; Humans; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology | 1984 |
Effects of high and low dosage of haloperidol on the brain in relation to schizophrenic thought disorder.
Topics: Hallucinations; Haloperidol; Hostility; Humans; Hypochondriasis; Schizophrenia; Schizophrenia, Paran | 1984 |
Haloperidol: therapeutic window in schizophrenia.
Topics: Adult; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male | 1994 |
Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia.
Topics: Adult; Chronic Disease; Corticotropin-Releasing Hormone; Double-Blind Method; Haloperidol; Humans; M | 1994 |
Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Chro | 1997 |
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Double-Blind Meth | 1997 |
Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade.
Topics: Adult; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor | 2000 |
Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels.
Topics: Adult; Antipsychotic Agents; Binding, Competitive; Female; Haloperidol; Humans; Male; Predictive Val | 2000 |
Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.
Topics: Adult; Aged; Analysis of Variance; Brief Psychiatric Rating Scale; Clinical Trials as Topic; Compute | 1975 |
Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
Topics: Adult; Anxiety; Chlorpromazine; Clinical Trials as Topic; Female; Haloperidol; Humans; Longitudinal | 1976 |
Computerized EEG: predictor of outcome in schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Computers; Drug Resistance; Electroencephalography | 1975 |
[Disagreement in standardized haloperidol treatment in comparison with "adequate individual dosage" of acutely schizophrenic patients].
Topics: Acute Disease; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol; Hu | 1992 |
[Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study].
Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Female; | 1991 |
Neuroleptic actions on the thyroid axis: different effects of clozapine and haloperidol.
Topics: Adult; Clozapine; Female; Haloperidol; Humans; Male; Schizophrenia, Paranoid; Schizophrenic Psycholo | 1991 |
Acute and subchronic effects of low-dose bromocriptine in haloperidol-treated schizophrenics.
Topics: Adult; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Metho | 1989 |
Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Depression; Dibenzazepines; F | 1987 |
104 other studies available for haloperidol and Delusional Disorder
| Article | Year |
|---|---|
Simultaneous bilateral ulnar neuropathy: an unusual complication caused by neuroleptic treatment-induced tardive dyskinesia: A Case Report.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Middle Aged; Schi | 2019 |
Monosymptomatic Hypochondriacal Psychosis (somatic delusional disorder): a report of two cases.
Topics: Adult; Affective Disorders, Psychotic; Amitriptyline; Antidepressive Agents, Tricyclic; Antipsychoti | 2013 |
Self-inflicted bilateral orchidectomy precipitated by erotic bizarre delusions: a case report.
Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Male; Prognosis; Recurrence; Schizophrenia, Parano | 2013 |
Are reduplicative paramnesia and clonal pluralization overlapping constructs?
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Capgras Syndrome; Clozapine; Diagnosis, Differential; | 2015 |
Adjusting Treatment for an Inmate-Patient Receiving Medication Involuntarily.
Topics: Adult; Antipsychotic Agents; Coercion; Commitment of Mentally Ill; Dangerous Behavior; Delayed-Actio | 2015 |
Fatal pulmonary embolism following antipsychotic treatment and physical restraint.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Fatal Outcome; Female; Haloperidol; Heart Arrest; Heart | 2009 |
Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia.
Topics: Adult; Affect; Antipsychotic Agents; Arousal; Beverages; Caffeine; Central Nervous System Stimulants | 2010 |
Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients.
Topics: Antipsychotic Agents; Benzodiazepines; Ectoparasitic Infestations; Female; Fluoxetine; Haloperidol; | 2010 |
Folie à deux: double case-report of shared delusions with a fatal outcome.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Clozapine; Combined Modality Therapy; | 2011 |
Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness.
Topics: Adolescent; Anti-Dyskinesia Agents; Antipsychotic Agents; Atropine; Benzodiazepines; Blindness, Cort | 2012 |
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Rel | 2013 |
Quetiapine-associated and dose-related hypomania in a woman with schizophrenia.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Diazepam; Dibenzothiazepines; Dose-Response Relations | 2002 |
Cerebral metabolism and risperidone treatment in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cerebellum; Cerebral Cortex; Chronic Disease; Energy Metabolism; Female | 2003 |
Clozapine and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Fema | 2003 |
Cerebral metabolic patterns in chronic and recent-onset schizophrenia.
Topics: Acute Disease; Adult; Basal Ganglia; Brain; Brain Mapping; Cerebellum; Cerebral Cortex; Chronic Dise | 2003 |
Use of adjunctive novel antipsychotics with depot haloperidol.
Topics: Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Delayed-Action Preparations; Diag | 2003 |
[ON THE TREATMENT OF PARANOID SCHIZOPHRENIA WITH HALOPERIDOL].
Topics: Haloperidol; Humans; Schizophrenia; Schizophrenia, Paranoid | 1964 |
Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol.
Topics: Adult; Dystonia; Female; Haloperidol; Humans; Injections, Intramuscular; Ocular Motility Disorders; | 2003 |
Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; | 2003 |
Alendronic acid for antipsychotic-related osteopenia.
Topics: Alendronate; Antipsychotic Agents; Bone Diseases, Metabolic; Female; Haloperidol; Humans; Middle Age | 2004 |
Improvement of torticollis with quetiapine in a schizophrenia patient.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administrati | 2004 |
[Influence of long-term quetiapine (Seroquel) and haloperidol therapy on cognitive deficit in patients with paranoid schizophrenia].
Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Cognition; Dibenzothiazepines; Female; Hal | 2004 |
[Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Commitment of Mentally Ill; Dr | 2006 |
[The syndrome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine].
Topics: Age Factors; Antipsychotic Agents; Dibenzothiazepines; Haloperidol; Humans; Hyponatremia; Inappropri | 2006 |
[Postictal paranoid-hallucinatory psychosis in cryptogenic epilepsy].
Topics: Acute Disease; Adult; Anticonvulsants; Cooperative Behavior; Delusions; Diazepam; Epilepsy; Epilepsy | 2007 |
Three cases of schizophrenia for which olanzapine was effective after early acute phase.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Foll | 2008 |
A case of paranoid schizophrenia complicated by scleroderma with associated esophageal dysmotility.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Case Management; Commitment of M | 2008 |
[Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; H | 1982 |
Therapeutic window for plasma haloperidol in acute schizophrenic psychosis.
Topics: Acute Disease; Adult; Female; Haloperidol; Humans; Schizophrenia, Paranoid | 1983 |
Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients.
Topics: Adult; Brief Psychiatric Rating Scale; Cholinergic Fibers; Cyclic GMP; Haloperidol; Humans; Male; Sc | 1984 |
Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
Topics: Adult; Aged; Amantadine; Antipsychotic Agents; Dementia; Dose-Response Relationship, Drug; Drug Ther | 1982 |
Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.
Topics: Adult; Biogenic Amines; Brief Psychiatric Rating Scale; Haloperidol; Homovanillic Acid; Humans; Hydr | 1983 |
Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.
Topics: Basal Ganglia; Basal Ganglia Diseases; Benzamides; Dose-Response Relationship, Drug; Female; Haloper | 1984 |
[Treatment of several psychotic states with the combination of valproic acid with diazepam].
Topics: Acute Disease; Adult; Delusions; Diazepam; Drug Therapy, Combination; Female; Hallucinations; Halope | 1984 |
The origin and treatment of rage attacks.
Topics: Alcohol Amnestic Disorder; Anger; Chlorpromazine; Drug Interactions; Haloperidol; Humans; Male; Prop | 1984 |
[Various methods of overcoming secondary resistance to treatment developing in relation to adaptation to psychotropic drugs during long-term treatment (clinico-experimental study)].
Topics: Adult; Animals; Catalepsy; Corpus Striatum; Disease Models, Animal; Drug Therapy, Combination; Drug | 1984 |
Haloperidol plasma levels and clinical response in paranoid schizophrenics.
Topics: Adult; Female; Haloperidol; Humans; Kinetics; Male; Middle Aged; Prolactin; Psychiatric Status Ratin | 1984 |
Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients.
Topics: Adult; Chlorpromazine; Dopamine; Fluphenazine; Haloperidol; Humans; Male; Norepinephrine; Schizophre | 1983 |
[Neuroleptic malignant syndrome with myoglobinuria].
Topics: Basal Ganglia Diseases; Female; Haloperidol; Humans; Middle Aged; Myoglobinuria; Rhabdomyolysis; Sch | 1983 |
Bromocriptine in the treatment of galactorrhea caused by haloperidol: a case study.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Haloperidol; Humans; Lactation Disorders; Pr | 1983 |
[Treatment of paranoid schizophrenia taking circadian biological rhythms into account].
Topics: Adolescent; Adult; Blood Pressure; Body Temperature; Circadian Rhythm; Delusions; Female; Hallucinat | 1984 |
[Complex use of phenazepam, lithium and haloperidol in the treatment of several forms of schizophrenia].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Caudate Nucleus; D | 1984 |
Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
Topics: Adult; Delusions; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Paranoid Disorders; Ps | 1983 |
High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study.
Topics: Adult; Dose-Response Relationship, Drug; Female; gamma-Aminobutyric Acid; Haloperidol; Homovanillic | 1982 |
Dislocated jaw concealed by dystonia.
Topics: Adult; Diagnosis, Differential; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Jaw; Joint Di | 1982 |
A fatality during haloperidol treatment: mechanism of sudden death.
Topics: Adult; Death, Sudden; Dose-Response Relationship, Drug; Female; Haloperidol; Heart Arrest; Humans; L | 1981 |
Anabolic steroids and acute schizophrenic episode.
Topics: Adolescent; Anabolic Agents; Haloperidol; Humans; Male; Schizophrenia, Paranoid; Self Medication | 1980 |
Psychiatric factors associated with dangerous misidentification delusions.
Topics: Adult; Capgras Syndrome; Chi-Square Distribution; Dangerous Behavior; Delusions; Demography; Female; | 1995 |
Quantitative EEG and BPRS data following Haldol-Decanoate administration in schizophrenics.
Topics: Adult; Alpha Rhythm; Antipsychotic Agents; Cerebral Cortex; Delayed-Action Preparations; Electroence | 1994 |
Self-inflicted enucleation of both eyes.
Topics: Adult; Eye Enucleation; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Religion and P | 1994 |
Coexistence of the delusions of infestation and body smell in schizophrenia: a case report.
Topics: Combined Modality Therapy; Delusions; Ectoparasitic Infestations; Female; Hallucinations; Haloperido | 1993 |
Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophrenia.
Topics: Adult; Chromatography, High Pressure Liquid; Female; Haloperidol; Humans; Male; Middle Aged; Psychia | 1994 |
Precipitation of dystonia by m-CPP in a schizophrenic patient treated with haloperidol.
Topics: Dystonia; Haloperidol; Humans; Male; Middle Aged; Piperazines; Schizophrenia, Paranoid; Serotonin; S | 1993 |
[Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
Topics: Adult; Antipsychotic Agents; Chlorprothixene; Diagnosis, Differential; Drug Therapy, Combination; Ha | 1995 |
Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
Topics: Adult; Antipsychotic Agents; Benperidol; Benzamides; Clozapine; Corpus Striatum; Dopamine Antagonist | 1996 |
[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benperidol; Benzamides; Bipolar Disorder; | 1997 |
[Treatment with haloperidol of clozapine-triggered drug-induced delirium].
Topics: Antipsychotic Agents; Clozapine; Delirium; Haloperidol; Humans; Male; Middle Aged; Schizophrenia, Pa | 1997 |
Late-onset psychosis: clinical, research, and ethical considerations.
Topics: Age of Onset; Antipsychotic Agents; Ethics, Medical; Female; Haloperidol; Humans; Male; Middle Aged; | 1999 |
[Diminution of hand writing area and D2-dopamine receptor blockade. Results from treatment with typical and atypical neuroleptics].
Topics: Adult; Aged; Antipsychotic Agents; Benzamides; Clozapine; Dopamine Antagonists; Female; Haloperidol; | 2000 |
Cannabis and psychosis.
Topics: Adolescent; Antipsychotic Agents; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Recurre | 2000 |
Could you spot this psych emergency?
Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Emergencies; Haloperidol; Humans; Male; Neurol | 2000 |
Atypical antipsychotic effects of quetiapine fumarate in animal models.
Topics: Amphetamine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Disease Models, Anima | 2000 |
No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
Topics: Adult; Antipsychotic Agents; Brain; Clozapine; Corpus Striatum; Female; Haloperidol; Humans; Male; M | 2001 |
[The Dolittle syndrome].
Topics: Adult; Animals; Antipsychotic Agents; Birds; Cats; Female; Hallucinations; Haloperidol; Humans; Schi | 1997 |
Association between severity of schizophrenic symptoms and urinary retention.
Topics: Acute Disease; Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Remission Induction; Schizo | 2001 |
Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia.
Topics: Adolescent; Adult; Brain; Chronic Disease; Clomipramine; Dopamine; Haloperidol; Humans; Male; Progno | 2002 |
[Dynamic study of blood cholinesterase activity of paranoid schizophrenic patients].
Topics: Adult; Butyrylcholinesterase; Cholinesterases; Drug Therapy, Combination; Haloperidol; Humans; Pheno | 1977 |
Neuroendocrine effects of haloperidol therapy in chronic schizophrenia.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Blood Gl | 1975 |
Cognitive abnormality in schizophrenia: a dual-process model.
Topics: Adolescent; Adult; Arousal; Attention; Chlorpromazine; Cognition Disorders; Color Perception; Concep | 1979 |
Coexisting tardive dyskinesia and parkinsonism: a case report.
Topics: Acetylcholine; Adult; Benztropine; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Fluphenazine | 1977 |
Comparative survey of psychiatrists' prescription preferences: New York and Texas.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Chlorpromazine; Drug Prescriptions; Drug Therapy, Co | 1975 |
Growth hormone secretion in chronic schizophrenia.
Topics: Adolescent; Adult; Chronic Disease; Female; Growth Hormone; Haloperidol; Humans; Insulin; Male; Midd | 1975 |
[The use of the brief psychiatric rating scale (BPRS) by overall and gorham for the diagnosis of acute paranoid psychoses: evaluation of a german translation of the BPRS (author's transl)].
Topics: Acute Disease; Germany, West; Haloperidol; Humans; Loxapine; Schizophrenia, Paranoid | 1975 |
Glucose-insulin metabolism in chronic schizophrenia.
Topics: Adult; Blood Glucose; Diabetes Complications; Glucose; Glucose Tolerance Test; Haloperidol; Humans; | 1976 |
Clozapine in the treatment of psychosis in an 82-year-old woman with tardive dyskinesia.
Topics: Age Factors; Aged; Aged, 80 and over; Clozapine; Dyskinesia, Drug-Induced; Female; Haloperidol; Huma | 1992 |
[Antibodies to neuroleptics and their role in the mechanisms of the development of drug resistance in psychopharmacotherapy of patients with paranoid schizophrenia].
Topics: Adult; Autoantibodies; Chlorpromazine; Dose-Response Relationship, Drug; Drug Resistance; Female; Ha | 1991 |
[3H]dopamine uptake by platelet storage granules in schizophrenia.
Topics: Adult; Analysis of Variance; Blood Platelets; Cytoplasmic Granules; Dopamine; Haloperidol; Humans; K | 1992 |
[Judicial aspects of treatment of incompetent psychiatric patients who categorically refuse treatment].
Topics: Adult; Combined Modality Therapy; Commitment of Mentally Ill; Dangerous Behavior; Expert Testimony; | 1991 |
[Cholinergic modulation on stereotyped behavior and behavioral hypersensitivity (reverse tolerance) in rats].
Topics: Animals; Cholinergic Fibers; Dopamine; Haloperidol; Methamphetamine; Pimozide; Rats; Rats, Inbred St | 1991 |
Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug | 1990 |
Effects of treatment with various doses of haloperidol on the pituitary-gonadal axis in male schizophrenic patients.
Topics: Acute Disease; Adult; Dose-Response Relationship, Drug; Haloperidol; Humans; Luteinizing Hormone; Ma | 1989 |
HLA antigens and neuroleptic response in clinical subtypes of schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Chromosome Mapping; Female; Gene Frequency; Haloperidol; HLA-A | 1989 |
Neurotoxicity resulting from a combination of lithium and loxapine.
Topics: Adult; Delirium; Dibenzoxazepines; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Loxapine | 1989 |
[Psychopathometric study of the prognostic significance of psychopathologic findings and premorbid personality for discharge of neuroleptic treated patients with schizophrenic psychoses].
Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Length of Stay; Paranoid Disorders; Personality Te | 1985 |
Effects of haloperidol on somatostatin-like immunoreactivity in the CSF of Schizophrenic patients.
Topics: Adult; Haloperidol; Humans; Male; Parasympatholytics; Psychiatric Status Rating Scales; Radioimmunoa | 1986 |
Gilles de la Tourette's syndrome associated with chronic schizophrenia.
Topics: Adolescent; Chronic Disease; Hallucinations; Haloperidol; Humans; Male; Naltrexone; Schizophrenia, P | 1988 |
Neuroleptic malignant syndrome in a man with mental retardation.
Topics: Adult; Haloperidol; Humans; Intellectual Disability; Male; Neuroleptic Malignant Syndrome; Schizophr | 1988 |
Antiaggressive effect of adjunctive clonazepam in schizophrenia associated with seizure disorder.
Topics: Adult; Aggression; Clonazepam; Drug Therapy, Combination; Electroconvulsive Therapy; Epilepsy, Tempo | 1988 |
Priapism and neuroleptics: a case report.
Topics: Biperiden; Drug Therapy, Combination; Haloperidol; Humans; Male; Middle Aged; Piperidines; Priapism; | 1988 |
Tolerance of a high dose of haloperidol by an elderly patient.
Topics: Aged; Drug Tolerance; Haloperidol; Humans; Male; Procyclidine; Pyrrolidines; Schizophrenia, Paranoid | 1988 |
Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.
Topics: Adult; Female; Haloperidol; Humans; Male; Neurocognitive Disorders; Phospholipases; Phospholipases A | 1987 |
Temporal lobe epilepsy with schizophrenia.
Topics: Aged; Carbamazepine; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Female; Haloperidol; Humans | 1987 |
[Value of neuroleptic therapy in the self assessment of schizophrenic patients].
Topics: Clozapine; Depressive Disorder; Dibenzazepines; Dyskinesia, Drug-Induced; Haloperidol; Humans; Psych | 1987 |
Bromocriptine in the treatment of neuroleptic-resistant schizophrenia.
Topics: Acute Disease; Adult; Bromocriptine; Drug Resistance; Drug Therapy, Combination; Haloperidol; Humans | 1986 |
Cerebrospinal fluid concentrations of free GABA in schizophrenia: no changes after haloperidol treatment.
Topics: Adult; gamma-Aminobutyric Acid; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizop | 1986 |
Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.
Topics: Adult; Arginine Vasopressin; Female; Haloperidol; Humans; Male; Oxytocin; Psychiatric Status Rating | 1985 |
Schizophrenia, psychoticism, neuroleptics, and auditory evoked potentials.
Topics: Adult; Arousal; Evoked Potentials, Auditory; Female; Hallucinations; Haloperidol; Humans; Male; Pers | 1985 |
Neuroleptic-induced priapism.
Topics: Adult; Haloperidol; Humans; Indoles; Male; Molindone; Priapism; Psychotic Disorders; Schizophrenia, | 1985 |
[Adaptation to neuroleptic preparations and several ways of combatting it (experimental study)].
Topics: Animals; Apomorphine; Catalepsy; Drug Therapy, Combination; Drug Tolerance; Haloperidol; Male; Mice; | 1985 |
Haloperidol and thyroid-binding globulin.
Topics: Adult; Haloperidol; Humans; Male; Schizophrenia, Paranoid; Thyroglobulin; Thyroid Function Tests | 1985 |
Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
Topics: Antipsychotic Agents; Depression; Haloperidol; Humans; Kinetics; Perphenazine; Phenothiazines; Piper | 1974 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorprom | 1974 |
Long-term effects of haloperidol.
Topics: Adolescent; Adult; Back Pain; Basal Ganglia Diseases; Bipolar Disorder; Depression; Depressive Disor | 1973 |
[Biochemical mechanisms of extrapyramidal-motoric effect of haloperidol in man].
Topics: Adult; Basal Ganglia Diseases; Female; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic A | 1974 |